Secreted by both the cancer cells and the cellular components of the tumor microenvironment, TGF-β also acts as a regulator of multiple biological processes essential in NSCLC progression, including angiogenesis, immunoevasion and immunosuppression [15,16]. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.